[Federal Register Volume 70, Number 210 (Tuesday, November 1, 2005)]
[Notices]
[Pages 65907-65908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-21649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; Comment Request; Assessment of the Use 
of Special Funding for Research on Type 1 Diabetes Provided by the 
Balanced Budget Act of 1997, the FY 2001 Consolidated Appropriations 
Act, and the Public Health Service Act Amendment for Diabetes

    Summary: Under the provisions of section 3507(a)(1)(D) of the 
Paperwork Reduction Act of 1995, the National Institute of Diabetes and 
Digestive and Kidney Diseases (NIDDK), the National Institutes of 
Health (NIH) has submitted to the Office of Management and Budget (OMB) 
a request for review and approval of the information collection listed 
below. This proposed information collection was previously published in 
the Federal Register on March 10, 2005, page 11994 and allowed 60 days 
for public comment. No public comments were received. The purpose of 
this notice is to allow an additional 30 days for public comment. The 
National Institutes of Health may not conduct or sponsor, the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.

Proposed Collection

    Title: Assessment of the Use of Special Funding for Research on 
Type 1 Diabetes Provided by the Balanced Budget Act of 1997, and the FY 
2001 Consolidated Appropriations Act, and the Public Health Service Act 
Amendment for Diabetes. Type of Information Collection Requested: 
Revision, OMB control number: 0925-0503; expiration date: 06/30/2005. 
Need and Use of Information Collection: This survey will be one source 
of input into a statutorily mandated assessment and report to the 
Congress on special funding for research on type 1 diabetes provided by 
the Balanced Budget Act of 1997, (Pub. L. 105-33), the FY 2001 
Consolidated Appropriations Act, (Pub. L. 106-554), and the Public 
Health Service Act Amendment for Diabetes, (Pub. L. 107-360). 
Collectively, these Acts provided $1.14 billion in special funds to the 
Department of Health and Human Services (HHS) for research aimed at 
understanding, treating, and preventing type 1 diabetes and its 
complications. The Secretary of HHS subsequently designated to the 
NIDDK the lead responsibility in the Department for developing a 
process for allocation of these funds. The primary objective of this 
study is to gain information, via a brief questionnaire, from NIH 
research grantees who were the primary recipients of these special 
funds, concerning their views on the impact of the type 1 diabetes 
research

[[Page 65908]]

fundings with respect to: (1) Advancing scientific accomplishments 
involving innovative, clinically relevant, and multidisciplinary 
research on type 1 diabetes; (2) developing resources or reagents 
useful for type 1 diabetes research; and (3) increasing the number and 
quality of type 1 diabetes investigators. The responses will provide 
valuable information concerning how the funds have facilitated research 
as intended by these Acts of the Congress. The results will also help 
determine how research progress from these special congressional 
initiatives fits within the continuum of diabetes research, and how 
these funds have contributed to the field of type 1 diabetes research 
and NIH efforts to combat this challenging health problem. Information 
from this study will aid in evaluation of the process by which the 
research goals for use of the special type 1 diabetes funds have been 
developed and are being pursued. Responses already collected from this 
survey were analyzed as part of an interim program assessment that was 
published by the NIDDK in April, 2003 http://www.niddk.nih.gov/federal/planning/type 1--specialfund/. This revised survey will contribute to a 
statutorily mandated report, due to the Congress on January 1, 2007, 
evaluating the process and efforts under this program and assessing 
research initiatives funded by these Act of Congress. Frequency of 
Response: The survey will require a one time response; though, 
respondents may be contacted again in the event of future 
congressionally mandated reports on the use of the special type 1 
diabetes research funds. Affected Public: Research scientists who 
received the special funds about which the Congress has mandated in law 
the requirements for an evaluation report. Type of Respondents: 
Laboratory and clinical investigators who have received support from 
the special type 1 diabetes funds provided under the laws previously 
cited. The annual reporting burden is as follows: Estimated number of 
respondents: 500; Estimated Number of Responses per Respondent: 1; 
Average Burden Hours per Response: 1; and Estimated Total Burden Hours 
Requested: 500. The annualized total cost to respondents is estimated 
at: $25,000. It is expected that the respondents will be contacted and 
will return their responses via electronic mail. These measures will 
reduce the burden on the respondents and the overall costs of 
administering the study. Respondents will be asked to answer no more 
than sixteen questions, one-third of which will be answered with 
``yes'' or ``no'' or a one-word response. There are no Capital Costs, 
Operating Costs or Maintenance Costs to report.

Request For Comments

    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
sued; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the burden of the 
collection of information on those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.

Direct Comments to OMB

    Written comments and/or suggestions regarding the item(s) contained 
in this notice, especially regarding the estimated public burden and 
associated response time, should be directed to the: Office of 
Management and Budget, Office of Regulatory Affairs, New Executive 
Office Building, Room 10235, Washington, DC 20503, Attention: Desk 
Officer for NIH. To request more information on the proposed project or 
to obtain a copy of the data collection plans and instruments, contact: 
Dr. Shefa Gordon, Presidential Management Fellow, Office of Scientific 
Program and Policy analysis, NIDDK, NIH, Building 31, Room 9A31, 9000 
Rockville Pike, Bethesda, MD 20892, or call non-toll-free number (301) 
496-6623 or e-mail your request, including your address, to: 
[email protected].

Comments Due Date

    Comments regarding this information collection are best assured of 
having their full effect if received within 30 days of the date of this 
publication.

    Dated: October 19, 2005.
Barbara Merchant,
Executive Officer, NIDDK.
[FR Doc. 05-21649 Filed 10-31-05; 8:45 am]
BILLING CODE 4140-01--M